Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-30

Clinical Trial Update: Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment. [NA]

View source ↗

Summary

A clinical trial is evaluating whether zinc and selenium supplementation affects HIV-infected individuals on antiretroviral therapy; the update provides status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)
  • ZINC (Zinc chloride)

Snippet

Sponsor: Instituto Nacional de Enfermedades Respiratorias | Conditions: HIV, ART | NA | Status: UNKNOWN